| Literature DB >> 19936287 |
Jennifer K Lee1, R Blaine Easley, Kenneth M Brady.
Abstract
Neurologic injury in patients with congenital heart disease remains an important source of morbidity and mortality. Advances in surgical repair and perioperative management have resulted in longer life expectancies for these patients. Current practice and research must focus on identifying treatable risk factors for neurocognitive dysfunction, advancing methods for perioperative neuromonitoring, and refining treatment and care of the congenital heart patient with potential neurologic injury. Techniques for neuromonitoring and future directions will be discussed.Entities:
Year: 2008 PMID: 19936287 PMCID: PMC2779352 DOI: 10.2174/157340308784245766
Source DB: PubMed Journal: Curr Cardiol Rev ISSN: 1573-403X
Preoperative Risk Factors for Perioperative Cerebral Injuries and Poor Neurodevelopmental Outcomes in Children with CHD
| Risk Factor | Examples |
|---|---|
| Genetic syndromes associated with abnormal neurodevelopment | Trisomy 21, velocardiofacial syndrome, DiGeorge, Turner,Williams, Alagille, CHARGE, and VACTERL [ |
| Abnormal | Delayed myelination, immature sulcation, decreased parenchymal volume [ |
| Congenital CNS abnormalities | Intracranial venous and cystic malformations [ |
| Complicated pre-operative course | Prematurity, IUGR, sepsis, mechanical ventilation, hemodynamic instability, persistent hypoxia with arterial saturation less than 85% [ |
| Brain injuries acquired pre-operatively | Injuries involving both superficial and deep white matter, focal strokes [middle, posterior, and anterior cerebral artery distributions], hemorrhages [intraventricular, subependymal, subdural] [ |
CHARGE, coloboma, heart defect, atretic choanae, retardation of growth and development, genitourinary anomalies, ear abnormalities; VACTERL: vertebral anomalies, anal atresia, cardiac anomaly, tracheoesophageal fistula, renal and limb abnormalities; IUGR, intra-uterine growth retardation; IVH, intraventricular hemorrhage.
Risk Factors during CPB for Perioperative Cerebral Injuries and Poor Neurodevelopmental Outcomes
| Risk Factor | Examples |
|---|---|
| Prolonged bypass time [ | |
| Obstructed cerebral venous drainage decreases CPP and CBF | Improperly sized venous cannulae, malpositioned cannulae, insufficient drainage systems, small tubing, airlocks in the circuit [ |
| Inflammation | Pediatric patients have a stronger inflammatory reaction to CPB than do adults due to a greater imbalance between proinflammatory and anti-inflammatory mediators [ |
| Embolic phenomena [ | Thromboemboli [ |
| Hemodilution [ | Anemia worsens cerebral oxygenation and increases the risk of ischemic injury [ |
| Anticoagulation [ | Intracranial bleeding, inflammatory response to heparin and protamine [ |
CPP, cerebral perfusion pressure; CBF, cerebral blood flow; CPB, cardiopulmonary bypass; BBB, blood-brain barrier; ICP, intracranial pressure; DHCA, deep hypothermic circulatory arrest; ACT, activated clotting time; CHD, congenital heart disease.
Postoperative Risk Factors for Perioperative Cerebral Injuries and Poor Neurodevelopmental Outcomes
| Risk Factor | Examples |
|---|---|
| Hypoxemia [ | Intrapulmonary shunting, pulmonary dysfunction, and continued venous and arterial mixing |
| Hemodynamic instability [ | Cardiac dysfunction, new shunt physiology, mechanical ventilation, pulmonary hypertension, fluid shifts, sedation |
| Anemia [ | |
| Inflammation | Cerebral edema with risk of elevated ICP, reperfusion injury [ |
| Elevated CVP decreases CPP and CBF | Obstructed bidirectional cavopulmonary anastomosis, SVCS [ |
| Elevated ICP decreases CPP | Post-bypass cerebral edema secondary to microemboli [ |
| Hyperthermia | Neuronal damage [ |
| Single-ventricle heart disease | Increased risk of post-operative cerebral emboli [ |
ICP, intracranial pressure; CVP, central venous pressure; CPP, cerebral perfusion pressure; CBF, cerebral blood flow; SVCS, superior vena cava syndrome; CHD, congenital heart disease.
Advantages and Limitations of Commonly Used, Noninvasive Neuromonitoring Techniques during CPB
| Technique | Advantages | Limitations |
|---|---|---|
| NIRS | Inexpensive; user friendly; indicates ongoing or impending cerebral ischemia through trends on a numeric scale; measuring oxygen consumption is one of the most reliable measures of brain metabolic activity [32]; detects differential perfusion pressure and oxygenation between cerebral hemispheres [ | May not detect ischemia to deep brain structures; measures oxygenation to only regional frontal cerebral cortex; wide inter-patient variability; reading may change depending on where the probe is positioned on the forehead; 75% of reading is from venous saturation. |
| EEG | Detects seizures that are not clinically apparent due to pharmacologic sedation and neuromuscular blockade; detects subclinical seizures; identifies burst suppression or electric silence during cooling [ | Technically difficult to use and interpret; numerous electrodes. |
| BIS | Simplified, user-friendly processed EEG; indicates cerebral ischemia [ | Not well tested in children younger than 2 years [ |
| TCD | Assesses cerebral autoregulation across changes in blood pressure and temperature [38]; can measure CBF once cerebral autoregulation is lost during hypothermic CPB [ | Cannot measure CBF volume if cerebral vascular resistance and perfusion pressure are changing; technically difficult to measure a specific cerebral artery when pulsatile perfusion is lost during CPB; only measures regional CBF. |
NIRS, near-infrared spectroscopy; COx, cerebral oximetry index; EEG, electroencephalogram; BIS, Bispectral Index; TCD, transcranial Doppler ultrasonography; CBF, cerebral blood flow; CPB, cardiopulmonary bypass; RLFP, retrograde low flow perfusion.
Treatment Algorithm Based on Changes in Neuromonitoring Parameters for Congenital Heart Surgery
| Neuromonitor | Normal | Abnormality | Intervention |
|---|---|---|---|
| Cerebral Oximetry (%) | 70%–90% | Pre/Post/During CPB: >20% reduction from baseline | Pre/Post/During CPB—increase CO, increase flow, adjust cannulae, increase PaCO2, increase MAP, increase temp, increase Hg, cross-correlate with other neuromonitors |
| During DHCA<30% | DHCA—cerebral reperfusion | ||
| BIS/EEG | >80/normal f/amp | Pre/Post/During CPB: >60/increased f/amp | Pre/Post CPB—increase anesthesia; if persists, consider seizure; cross-correlate with other neuromonitors |
| <30/decreased f/amp (during rewarming) | During CPB—increase anesthesia on pump, lower temp | ||
| During DHCA: Not 0/not isoelectric | DHCA—continue cooling before DHCA | ||
| TCD (mean CBFV) | Normal (see table 4) or baseline CBFV | Pre/Post/During CPB: >25% decrease from baseline | Pre/Post CPB—evaluate TCD transducer position, cross-correlate neuromonitors (i.e., check cerebral oximeter; if low, increase CO, MAP, PaCO2) |
| >25% increase from baseline | Pre/Post/During CPB—increase anesthesia depth, decrease PaCO2, MAP | ||
| HITS | Pre/Post CPB—possible emboli. |
CPB, cardiopulmonary bypass; DHCA, deep hypothermic circulatory arrest; CO, cardiac output; Hg, hemoglobin; PaCO2, arterial carbon dioxide content; MAP, mean arterial pressure; BIS, bispectral index; EEG, electroencephalography; f, frequency of electrical EEG waves; amp, amplitude of electrical EEG waves; TCD, transcranial Doppler; CBFV, cerebral blood flow velocity; HITS, high intensity transient signals; TEE, transesophageal echocardiography; ECG, electrocardiography. (Adapted from [38] and [112]).
Normal Transcranial-Doppler Velocities for Infants, Children, and Adults
| Age | Depth (mm) | Mean Velocity (cm/s) | Peak Systolic Velocity (cm/s) | End–diastolic Velocity (cm/s) |
|---|---|---|---|---|
| 0–3 months | 25 | (24–42)±10 | (46–75)±15 | (12–24)±8 |
| 3–12 months | 30 | 74±14 | 114±20 | 46±9 |
| 1–3 years | 35–45 | 85±10 | 124±10 | 6±11 |
| 3–6 years | 40–45 | 94±10 | 147±17 | 65±9 |
| 6–10 years | 45–50 | 97±9 | 143±13 | 72±9 |
| 10–18 years | 45–50 | 81±11 | 129±17 | 60±8 |
| 18–40 years | 45–50 | 81±20 | 120±28 | 55±13 |
| 41–60 years | 45–50 | 73±19 | 109±22 | 49±13 |
Normal transcranial-Doppler velocities in the middle cerebral artery monitored through the temporal window in awake subjects without congenital heart disease (mean ± SD). (Adapted from [65,66,67].)